ResMed, Inc. (NYSE:RMD)
The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
Their sleep apnea devices are the best in the industry.
Recs
Medicare reimbursement cuts affect ~30% of revenues directly. Will also put pricing pressure on them down the line as this signals a market shift. I would expect multiple compression in light of new headwinds.
Recs
CPAP devices are in demand as sleep apnea diagnoses are on the rise.
Recs
This company manufactures a proven sleep apnia device that is effective in solving adult apnia issues. The product is recommended by doctors presently. There is a growing population of probable customers, baby boomer generation
Recs
Great competitive position
Macro headwinds
Recs
Because their strongest competitor, Respironics, has been bought by another company.
Recs
ResMed manufactures sleep apnea equipment. Low debt, good sales + earnings growth, and a huge untapped market make ResMed a 'buy'. When they come out with home testing equipment I think many more people will be diagnosed with this condition and subsequently be treated for it.
Recs
Strong fundamentals, good price pattern
Recs
this company has a unique product, with little to no competition in it's industry, it possesses a book value of $175 per share, and is trading way below that value and it's intrinsic value. Not to mention the company has a great balance sheet and income statement. This is a golden chicken egg just waiting to hatch.
Recs
It is the most undervalued company in the market with strong growth, sound management and outstanding demand demographics. It is a pure play on the population being overweight and aging in US, Europe and Asia.
Recs
The CPAP machine I use is by Fisher & Paykel Healthcare but ResMed's equipment is ubiquitous in the diagnostic and treatment centers for sleep disorders. Growing market share and a 20% yoy share price increase makes it a dependable, if not spectacular performer.
Recs
At the bottom and going up
Recs
Agree w/2 of 8 StockScouter picks for 09/08.
Personally use their products every night.
Saved my marriage!
Recs
steady growth
Recs
rec'd it, then it ran on the resp acquisition. has come back now and long term i like it.
Recs
No other devices come close to it
Recs
Down because of a recall, but this is still a very good business, seems well-managed. good time to buy.
Recs
Next Qtr will show everyone the growth is back
Recs
Buy on weakness.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 39 : 1 2 Next »